119 related articles for article (PubMed ID: 37455213)
1. Comprehensive Analyses Revealed Eight Immune Related Signatures Correlated With Aberrant Methylations as Prognosis and Diagnosis Biomarkers for Kidney Renal Papillary Cell Carcinoma.
Luo Y; Chen D; Xing XL
Clin Genitourin Cancer; 2023 Oct; 21(5):537-545. PubMed ID: 37455213
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA related prognosis biomarkers from high throughput sequencing data of kidney renal papillary cell carcinoma.
Yao ZY; Xing CQ; Zhang T; Liu YW; Xing XL
Eur Rev Med Pharmacol Sci; 2021 Mar; 25(5):2235-2244. PubMed ID: 33755961
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Analysis of Ferroptosis- and Immune-Related Signatures to Improve the Prognosis and Diagnosis of Kidney Renal Clear Cell Carcinoma.
Xing XL; Liu Y; Liu J; Zhou H; Zhang H; Zuo Q; Bu P; Duan T; Zhou Y; Xiao Z
Front Immunol; 2022; 13():851312. PubMed ID: 35619698
[TBL] [Abstract][Full Text] [Related]
4. cg04448376, cg24387542, cg08548498, and cg14621323 as a Novel Signature to Predict Prognosis in Kidney Renal Papillary Cell Carcinoma.
Wang YL; Zhang YY
Biomed Res Int; 2020; 2020():4854390. PubMed ID: 33381555
[TBL] [Abstract][Full Text] [Related]
5. Construction autophagy-related prognostic risk signature combined with clinicopathological validation analysis for survival prediction of kidney renal papillary cell carcinoma patients.
Fei H; Chen S; Xu C
BMC Cancer; 2021 Apr; 21(1):411. PubMed ID: 33858375
[TBL] [Abstract][Full Text] [Related]
6. Prognostic risk signature based on the expression of three m6A RNA methylation regulatory genes in kidney renal papillary cell carcinoma.
Sun Z; Jing C; Xiao C; Li T; Wang Y
Aging (Albany NY); 2020 Nov; 12(21):22078-22094. PubMed ID: 33177247
[TBL] [Abstract][Full Text] [Related]
7. An
Fu S; Gong B; Ding Y; Zhuang C; Chen Q; Wang S; Li Z; Ma M; Liu Y; Zhang Z; Sun T
Comb Chem High Throughput Screen; 2022; 25(13):2278-2294. PubMed ID: 35293292
[TBL] [Abstract][Full Text] [Related]
8. Construction and validation of an autophagy-related long non-coding RNA signature to predict the prognosis of kidney renal papillary cell carcinoma.
Kang Z; Yang J
J Investig Med; 2022 Oct; 70(7):1536-1544. PubMed ID: 35725019
[TBL] [Abstract][Full Text] [Related]
9. Identification of prognostic stemness-related genes in kidney renal papillary cell carcinoma.
Liu Y; Yao Y; Zhang Y; Xu C; Yang T; Qu M; Lu B; Song X; Pan X; Zhou W; Cui X
BMC Med Genomics; 2024 May; 17(1):121. PubMed ID: 38702698
[TBL] [Abstract][Full Text] [Related]
10. Bioinformatic analysis highlights SNHG6 as a putative prognostic biomarker for kidney renal papillary cell carcinoma.
Liu Y; Cheng X; Xi P; Zhang Z; Sun T; Gong B
BMC Urol; 2023 Apr; 23(1):54. PubMed ID: 37004005
[TBL] [Abstract][Full Text] [Related]
11. Construction and Analysis of lncRNA-miRNA-mRNA ceRNA Network Identify an Eight-Gene Signature as a Potential Prognostic Factor in Kidney Renal Papillary Cell Carcinoma (KIRP).
Yang L; Ma TJ; Zhang YB; Wang H; An RH
Altern Ther Health Med; 2022 Sep; 28(6):42-51. PubMed ID: 35648698
[TBL] [Abstract][Full Text] [Related]
12. A Two-DNA Methylation Signature to Improve Prognosis Prediction of Clear Cell Renal Cell Carcinoma.
Shi S; Ye S; Wu X; Xu M; Zhuo R; Liao Q; Xi Y
Yonsei Med J; 2019 Nov; 60(11):1013-1020. PubMed ID: 31637882
[TBL] [Abstract][Full Text] [Related]
13. PYCR in Kidney Renal Papillary Cell Carcinoma: Expression, Prognosis, Gene Regulation Network, and Regulation Targets.
Shao Z; Lu L; Cui Y; Deng L; Xu Q; Liang Q; Lu X; Zhang J; Chen J; Situ Y
Front Biosci (Landmark Ed); 2022 Dec; 27(12):336. PubMed ID: 36624948
[TBL] [Abstract][Full Text] [Related]
14. System analysis of
Situ Y; Xu Q; Deng L; Zhu Y; Gao R; Lei L; Shao Z
Int J Biol Markers; 2022 Mar; 37(1):90-101. PubMed ID: 34870494
[TBL] [Abstract][Full Text] [Related]
15. Designing a predictive Framework: Immune-Related Gene-Based nomogram and prognostic model for kidney renal papillary cell carcinoma.
Lim A; Edderkaoui M; Zhang Y; Wang Q; Wang R; Pandol SJ; Ou Y
Int Immunopharmacol; 2024 Apr; 131():111878. PubMed ID: 38493693
[TBL] [Abstract][Full Text] [Related]
16. Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma.
Song J; Liu YD; Su J; Yuan D; Sun F; Zhu J
J Cell Physiol; 2019 Dec; 234(12):22753-22764. PubMed ID: 31140607
[TBL] [Abstract][Full Text] [Related]
17. Identification of Two Immune Related Genes Correlated With Aberrant Methylations as Prognosis Signatures for Renal Clear Cell Carcinoma.
Yao ZY; Xing C; Liu YW; Xing XL
Front Genet; 2021; 12():750997. PubMed ID: 34925447
[TBL] [Abstract][Full Text] [Related]
18. A five-gene methylation signature predicts overall survival of patients with clear cell renal cell carcinoma.
Jing X; Xu G; Gong Y; Li J; LingfengWu ; Zhu W; He Y; Li Z; Pan S
J Clin Lab Anal; 2021 Dec; 35(12):e24031. PubMed ID: 34716619
[TBL] [Abstract][Full Text] [Related]
19. Identification of Prognostic Biomarkers for Clear Cell Renal Cell Carcinoma (ccRCC) by Transcriptomics.
Zhang S; Xu X; Wang Y; Zhu Y; Wang J; Wang H; Guo J
Ann Clin Lab Sci; 2021 Sep; 51(5):597-608. PubMed ID: 34686501
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of CDCA3 in kidney renal papillary cell carcinoma.
Li H; Li M; Yang C; Guo F; Deng S; Li L; Ma T; Yan J; Wu H; Li X
Aging (Albany NY); 2021 Dec; 13(23):25466-25483. PubMed ID: 34905505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
